Thermo Fisher Scientific (TMO) filed a registration statement Monday with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings.
The filing covers debt securities, common stock, preferred stock, depositary shares, purchase contracts, units,
warrants, and guarantees, and includes the potential offering of debt securities by Thermo Fisher Scientific B.V.
Net proceeds will be used for general corporate purposes, which may include acquisitions, debt repayment and refinancing, working capital and capital expenditures or the repurchase of shares, the company said.
TMO shares were 1.6% higher in recent trading.
Price: 541.16, Change: +8.61, Percent Change: +1.62
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.